Abstract
Antiphospholipid antibodies (aPL) may occur alone or associated with other diseases. To evaluate aPL, tested as anticardiolipin antibodies (IgG aCL) in infective endocarditis (IE) diagnosis, we investigated their prevalence in a cohort of 651 patients with IE suspicion. aPL was significantly associated with definite IE versus IE-rejected patients. Their mean levels were significantly higher in patients with definite IE versus possible IE. When applied as Duke minor criterion, they were significantly more often positive, and at higher levels, in patients with definite IE than in patients with possible or rejected IE. aPL could be helpful in difficult cases of IE diagnosis.
Similar content being viewed by others
References
Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368(11):1033–1044
Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019–1027
Pardos-Gea J, Avegliano G, Evangelista A, Vilardell M, Ordi-Ros J (2013) Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study. Int J Rheum Dis 18(1):76–83
Koniari I, Siminelakis SN, Baikoussis NG, Papadopoulos G, Goudevenos J, Apostolakis E (2010) Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. J Cardiothorac Surg 5:101
Greaves M, Cohen H, Machin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109(4):704–715
Million M, Walter G, Bardin N et al (2013) Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis 57(1):57–64
Contractor T, Bell A, Khasnis A, Silverberg BJ, Martinez MW (2013) Antiphospholipid antibody-associated non-infective mitral valve endocarditis successfully treated with medical therapy. J Heart Valve Dis 22(1):36–38
Raoult D, Casalta JP, Richet H et al (2005) Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43(10):5238–5242
Fournier PE, Thuny F, Richet H et al (2010) Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51(2):131–140
Verrot D, San-Marco M, Dravet C et al (1997) Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 103(1):33–37
Mahr A, Batteux F, Tubiana S et al (2014) Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol 66(6):1672–1677
Zuily S, Regnault V, Selton-Suty C et al (2011) Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 124(2):215–224
Djokovic A, Stojanovich L, Kontic M, Stanisavljevic N, Radovanovic S, Marisavljevic D (2014) Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome. Isr Med Assoc J 16(3):162–167
Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H (1999) The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 33(5):1365–1371
Bojalil R, Mazón-González B, Carrillo-Córdova JR, Springall R, Amezcua-Guerra LM (2012) Frequency and clinical significance of a variety of autoantibodies in patients with definite infective endocarditis. J Clin Rheumatol 18(2):67–70
Ying CM, Yao DT, Ding HH, Yang CD (2014) Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review. PLoS One 9(2):e89777
Aslangul E, Goulvestre C, Mallat Z, Mainardi JL (2014) Human bartonella infective endocarditis is associated with high frequency of antiproteinase 3 antibodies. J Rheumatol 41(2):408–410
Acknowledgements
We thank Pr Jean-Louis Mege for his help in the critical review of the article.
Authorship
All authors had access to the data and contributed to the writing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding source
None.
Conflict of interest
None.
Informed consent
Each patient provided written consent.
Ethical approval
The study was approved by the local ethics committee (number 12-016).
Rights and permissions
About this article
Cite this article
Zaratzian, C., Gouriet, F., Tissot-Dupont, H. et al. Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 36, 1159–1162 (2017). https://doi.org/10.1007/s10096-017-2903-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-017-2903-1